A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Japanese Phase 1 Study of BMS-844203 (CT322)
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I
- Status
- WITHDRAWN
- Phase
- PHASE2
Dose Escalation With Remicade® and Orencia®
- Status
- COMPLETED
- Phase
- N/A
Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients
- Status
- COMPLETED
- Phase
- N/A
Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents
- Status
- COMPLETED
- Phase
- N/A
Pediatric Catheter-related Thrombosis Imaging Study
- Status
- COMPLETED
- Phase
- NA
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
- Status
- COMPLETED
- Phase
- PHASE3
Predictors of Adherence to Orencia
- Status
- COMPLETED
- Phase
- N/A
Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)
- Status
- COMPLETED
- Phase
- N/A
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Saxagliptin Triple Oral Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients
- Status
- COMPLETED
- Phase
- PHASE2